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SUMMARY
It is not uncommon to set the sample size in a clinical trial to attain speciﬁed power at a value for the treatment
effect deemed likely by the experimenters, even though a smaller treatment effect would still be clinically important.
The papers by Fisher (1998) and Cui, Hung & Wang (1999) concern the situation where such a study produces only
weakevidenceof a positivetreatment effectat an interimstage andthe organizerswishto modifythe designinorder to
increase the power to detect a smaller treatment effect than originally expected. Raising the power at a small treatment
effect usually leads to considerably higher power than was ﬁrst speciﬁed at the original alternative.
In both the above papers, methods are proposed which are not based on sufﬁcient statistics of the data after the
adaptive re-design of the trial. We discuss these proposals and show how the same objectives can be met while
maintaining the sufﬁciency principle, as long as the eventuality that the treatment effect may be small is considered
at the design stage. The group sequential designs we suggest are quite standard in many ways but unusual in that
they place emphasis on reducing the expected sample size at a parameter value under which extremely high power is
to be achieved. Comparisons of power and expected sample size show that our proposed methods can out-perform
L. Fisher’s “variance spending” procedure. Although the ﬂexibility to re-design an experiment in mid course may be
appealing, the cost in terms of the number of observations needed to correct an initial design may be substantial.
Key words: Clinical trials; Group sequential tests; Sample size re-estimation;Two-stage procedure; Flexible
design; Variance spending.
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11 Introduction
We consider a situation which is not unusual in Phase III clinical trials that involve the comparison of a new
treatment with a placebo or standard therapy. A statistical design is speciﬁed in the protocol based in part on
speciﬁcation of a Type I error rate,
￿ , and power
￿
￿
￿
￿
￿ at a given effect size,
￿ . The design may be ﬁxed or
there may be provision forearly stopping via a groupsequential monitoringboundary. Atsome intermediate
point during the course of the trial, the principal investigators examine the outcome data collected so far and
decide they wish to modify the original design. They may, for example, have been over-optimistic in the
choice of the design effect size,
￿ , whereas it is now apparent that the beneﬁt of the new treatment is liable
to be somewhat less than
￿ and it is unlikely that a signiﬁcant result will be achieved at the planned end
of the trial. Even so, the estimated effect may still be large enough to be deemed clinically signiﬁcant and
worthwhile.
At this stage, the question is often posed to the study statistician (and perhaps to a regulatory body, such
as the FDA) whether the trial design can be modiﬁed and the sample size enlarged, without violating the
trial’s credibility and statistical validity. In the past, a strict answer to this question was usually “No”. The
alternative strategy of abandoning a trial if early results appear unpromising and starting a new trial can also
lead to grossly inﬂated Type I error rates — in extreme, this is akin to “sampling to a foregone conclusion”
(Cornﬁeld, 1966). However, recently Fisher (1998), and Shen & Fisher (1999) have proposed the so-called
“variance spending” method whereby the sample size and other features of the current trial can be modiﬁed
while maintaining the
￿ level, even though these modiﬁcationswere unplannedat the start of the trial. Other
authors have proposed similar and related methods that can adapt a design to interim outcome data. These
include Bauer & Köhne (1994), Proschan & Hunsberger (1995), Lan & Trost (1997), Cui, Hung & Wang
(1999), Lehmacher & Wassmer (1999), Chi & Liu (1999), Denne (2000, 2001), Müller & Schäfer (2000,
2001) and Wang, Hung, Tsong & Cui (2001). Wassmer (2000) summarizes and reviews many of these
articles. In some of these papers, the authors describe methods in which the design is changed in response
to interim results according to pre-speciﬁed rules; other methods offer greater freedom to adapt to interim
data in an unplanned way. Fisher (1998) emphasizes that the variance spending method allows mid-course
changes in trial design “undreamed of” before the study started and such considerations lead him to term
these “self-designing” trials.
In the next section we describe an example of a trial in which examination of response data at an
unplanned interim analysis suggests a larger study should have been conducted. In Section 3 we show how
Fisher’s variance spending method can overcome this problem, we explain its equivalence to other methods
2and present new methodologyfor deriving a conﬁdence interval on termination; for the most part we conﬁne
attentiontothetwo-stagemethodproposedbyFisher(1998), butwemakeoccasionalremarksonmulti-stage
versions. In order to assess the efﬁciency of the variance spending method it is necessary to consider its use
with a fully speciﬁedrule for revising sample size. In Section 3.4 we present a typical version of sample size
rule and in Section 3.5 we discuss possible inefﬁciencies in the variance spending approach due to use of a
non-sufﬁcient statistic and variability in the ﬁnal sample size. In Section 4 we calculate the overall power
function and average sample size function of this procedure and show that ﬂexibility does not come without
a price. In comparison, we present standard group sequential procedures which provide the same power for
fewer observations on average: these procedures could have been used had the experimenters considered
the possibility of a smaller effect size and agreed on a minimal clinically signiﬁcant effect size at the initial
designstage. Our conclusionis thatmore carefulinitialplanningcan lead to signiﬁcant savingsin resources.
Although ﬂexible procedures allow a mid-course correction to be made in a statistically valid manner, it is
better still to determine on the correct objective at the start.
Note that the sample size re-estimation procedures we consider here should not be confused with those
used when there is an unknown nuisance parameter such as a response variance. There is already an
extensive literature on this topic; see, for example, the recent paper by Whitehead et al (2001) or, for a
survey, Jennison & Turnbull (2000, Chapter 14). The procedures are also not to be confused with adaptive
designs where treatment allocation proportions can be varied depending on accumulating results. The even
more numerous papers on this topic are surveyed in Jennison & Turnbull (2000, Chapter 17).
2 Problems posed by unplanned interim analyses
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￿ . Although this problem may seem unrealistically simple, it does in fact serve as a prototype for a wide
variety of responses, and methods developed for this situation have wide applicability; see, for example,
Jennison & Turnbull (2000, Chapter 3).
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Cui et al (1999) show that, typically, the Type I error rate of such a test is inﬂated by
c
#
￿
d
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e
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d
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other rules to determine the second stage sample size, it can more than double — see Proschan, Follmann &
Waclawiw (1992, Table 4) and Proschan & Hunsberger (1995).
The experimenters may consider the alternative option of ignoring the data collected so far and starting
a completely new trial with a larger sample size. Not only is this wasteful of data but, as noted in Section 1,
persistent use of this strategy is liable to produce an excess of false positive results in a manner akin to the
process of sampling to a foregone conclusion discussed by Cornﬁeld (1966).
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L. Fisher’s variance spending approach
3.1 Deﬁnition
Fisher (1998) has proposed a method which allows changes to the sample size at an unplanned interim
analysis while still preserving the Type I error rate. At an intermediate stage when
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In the variance spending framework,
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The variance spending approach can be extended to allow more than one re-design point. Fisher (1998)
and Shen & Fisher (1999) describe a multi-stage procedure in which a ﬁnal
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3.2 Equivalent methods
Cui et al (1999) propose a method for modifying group sizes in the later stages of a group sequential test
while maintaining the original Type I error rate. The following description generalizes their procedure to
allow morethan onere-design point— althoughin practiceat most onechange to a trial’sprotocol may well
be desirable. In the original design, the
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Fisher’s variance spending approach. With a single re-design point, the factors
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exactly Fisher’s two-stage variance spending test.
Ifaformalinterimanalysisis includedinatrialprotocol,onewouldexpecttheexperimenterstoconsider
the option of stopping to reject or to accept
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) at the interim analysis. When a variance spending test is
adopted because of an unplanned interim analysis, such early stopping is not strictly allowable. However, if
interim results are very negative, one may decide for ethical or economic reasons to stop for “futility” with
acceptance of
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) ; indeed, Shen & Fisher (1999) advocate the use of such a futility boundary. This can only
reduce the Type I error, producing a conservative test.
Another method for adapting a group sequential test to deal with data-dependent modiﬁcations to group
sizes has been proposed by Denne (2001) and Müller & Schäfer (2000, 2001). The key to this method is
preserving the conditional Type I error probability, given current data and the original experimental design,
when the future course of the trial is changed. The following calculation shows that applying this principle
at stage one of a two-stage group sequential test with re-calculation of the remaining sample size but no
stopping at the ﬁrst stage yields Fisher’s variance spending test. With the notation of Section 3.1, if
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There is good reason why all these methods should be equivalent. Integrating over the distribution of
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— and the preceding discussion shows the ﬁnal decision rule is therefore that of Fisher’s
variance spending test.
Several authors, including Chi & Liu (1999) and Wassmer (1998), have described the two-stage tests of
Bauer & Köhne (1994) and Proschan & Hunsberger (1995) in a common framework. In these procedures,
the second stage design is chosen in the light of ﬁrst stage outcomes and data from the two stages are
combined according to a pre-speciﬁed rule. Responses from each stage can be summarized by a
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same manner since it is applicable in the absence of any initial intent to use a two-stage procedure. In this
case, the ﬁxed sample analysis originally planned determines the conditional Type I error function
￿
3
￿
F
;
deﬁned in (6) and this plays the same role as
¥
3
5
4
F
;
above.
3.3
“ -values and conﬁdence intervals
It is useful to augment the result of a hypothesis test by stating a
￿
-value for testing the null hypothesis
and a conﬁdence interval for the parameter of interest. In a two-stage variance spending test with no early
stopping at the ﬁrst stage, deﬁning a
￿
-value of the observed data for testing
(
*
) :
&
￿
￿
#
is straightforward.
Since the standardized statistic
[
deﬁned by (4) has a standard normal distribution under
(
*
) , the one-sided
￿
-value for testing
(
) against
&
'
,
#
is simply
G
u
￿
«
￿
￿
￿
n
C
3
[
;
￿
Shen & Fisher (1999, p. 197) note that their method does not provide an estimate of
& . In the following,
we overcome the complication that
X , and hence the mean of
i
  , depends on
i
F to produce a conﬁdence
interval for
& . This derivation generalizes to Shen & Fisher’s multi-stage setting. In a two-stage variance
spending test, as deﬁned in Section 3.1,
i
F
￿
￿
I
2
&
j
‘
3
#
￿
l
I
2
;
and
X
E
!
F
t
s
t
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￿
\
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￿
￿
￿
/
I
;
2
&
j
‘
3
#
￿
3
￿
￿
￿
R
I
;
2
;
independently of
i
F . Thus,
i
F
8
X
E
!
F
t
s
t
 
i
 
￿
￿
I
8
\
X
3
￿
￿
￿
R
I
;
￿
￿
2
&
j
‘
3
#
￿
2
;
so
￿
￿
￿
¢
‹
￿
4
7
6
\
2
ﬁ
›
i
F
8
X
E
!
F
t
s
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i
 
￿
￿
I
8
\
X
3
￿
Z
￿
/
I
;
￿
￿
2
&
›
4
b
6
\
2
￿
ﬂ
￿
«
￿
￿
￿
n
￿
and, by the usual pivoting argument,
i
F
8
X
!
E
!
F
t
s
t
 
i
 
￿
I
8
\
X
3
￿
￿
￿
R
I
;
￿
￿
2
⁄
￿
4
7
6
￿
I
8
\
X
3
￿
Z
￿
R
I
;
￿
\
2
is a
￿
Z
￿
n
￿ conﬁdence interval for
& .
9This conﬁdence interval can also be derived by inverting a family of tests of hypotheses
( :
&
–
￿
¡
&
where the critical region of each test is deﬁned using the conditional error probability argument applied in
testing
(
*
) in Section 3.2. This method has the advantage of extending to the adaptively re-designed group
sequential tests of Cui et al (1999).
A more troublesome problem arises if unplanned early stopping is introduced at an interim stage,
such as stopping for futility with acceptance of
(
) when a positive result looks very unlikely. It is then
unclear what the space of outcomes that could have arisen really is (to specify this, one needs to say what
the experimenters would have decided to do in every possible eventuality) and this appears to preclude
construction of a conﬁdence interval with the required frequentist coverage probability.
3.4 A rule for choosing
†
The prime motivation for variance spending tests and related methods is the desire for ﬂexible modiﬁcation
of a trial design in response to intermediate results when no such adaptation was originally planned.
Nevertheless, it is helpful to consider formal rules for how such adaptation might be carried out. Examining
the overall properties of response adaptive designs conducted according to speciﬁc rules will aid in
understanding these methods and help assess the cost, in terms of efﬁciency, of this ﬂexibility.
As before, we denote by
J
&
F
￿
i
F
V
3
I
2
;
the estimate of
& computed from
I
2 observations per treatment
arm observed at an unplanned, intermediateanalysisand deﬁne
T
0
￿
1
￿
￿
V
J
&
F . Fisher (1998)discusses a strategy
for choosing
X to obtain conditional power
￿
‡
￿
·
￿ , given the data observed so far, if in fact
&
0
￿
1
￿
=
V
b
T
?
￿
J
&
F . In
the original ﬁxed sample test, the conditional power given
i
F
￿
1
￿
F under
&
￿
￿
J
&
F is
C
9
¶
￿
I
8
\
X
3
￿
￿
￿
/
I
;
￿
\
2
J
&
F
￿
4
7
6
\
3
￿
￿
￿
R
I
;
•
and equating this probability to
￿
Z
￿
￿
￿ gives
X
￿
￿
3
\
￿
￿
￿
/
I
4
￿
:
’
8
–
4
b
6
￿
/
I
\
2
J
&
F
;
 
3
￿
W
￿
/
I
;
 
2
J
&
 
F
￿ (9)
Some truncation may be necessaryto ensure that
X is positive but does not exceeda reasonableupper bound.
We shall pursue the alternative proposal by Cui et al (1999) of equating the total sample size to that
which would achieve unconditional power
￿
.
￿
￿
￿ for a true value of
& equal to
J
&
F , but we adapt this rule to
allow for the special weighting of the second stage data. Suppose
X were ﬁxed and independent of the ﬁrst
stage data. Then
m
F and
m
  would be independent and, by (2) and (3),
[
￿
‚
m
F
8
m
 
j
‘
3
￿
I
8
\
X
3
￿
￿
￿
/
I
;
￿
\
2
&
k
￿
Q
￿
;
￿
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ﬁxed sampletest designedfrom the outsetto achieve power
￿
Q
￿
S
￿ at
&
0
￿
1
￿
=
V
b
T would have
T
 
2 observations
per treatment arm and use a standardized test statistic
[
z
”
with distribution
[
”
j
‘
3
T
\
2
&
k
￿
Q
￿
;
￿
Equating the means of
[
and
[
”
gives
T
?
￿
Y
I
8
\
X
3
￿
Z
￿
R
I
;
or, equivalently,
X
·
￿
￿
T
S
￿
/
I
￿
￿
￿
R
I
￿
 
￿ (10)
If
J
&
F is small and positive,
T and
X will be very large. Thus, it is advisable to bound the value of
T used
in (10). Since a small positive value of
& may give rise to negative values of
J
&
F , the maximal value of
X is
also appropriate for negative
J
&
F . (However, if
J
&
F is sufﬁciently low, one may choose to abandon the trial
for futility and stop at this point with acceptance of
(
*
) .) If
J
&
F
,
1
￿ , then
T
g
￿ and the above rule leads to
X
g
￿ , i..e., a decrease in the second stage sample size. This is quite acceptable but at least some truncation
is necessary to keep
X positive. With these modiﬁcations, we obtain the general rule
X
3
J
&
F
;
￿
‚
»
¡
T
3
J
&
F
;
￿
R
I
￿
￿
￿
/
I
…
 
(11)
where
¡
T
3
J
&
F
;
￿
￿
‰
¿
¿
¿
¿
￿
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¿
¿
`
￿
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J
&
F
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￿
￿
›
￿
E
!
F
￿
=
V
J
&
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￿
E
!
F
g
J
&
F
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￿
￿
›
˜
ˆ
E
>
F
ˆ for
J
&
F
V
￿
￿
0
,
ˆ
E
!
F
￿
￿
(12)
The values of
X generated by this rule lie in the range
3
ˆ
￿
'
I
;
 
V
3
￿
￿
￿
'
I
;
  to
3
￿
￿
'
I
;
 
V
3
￿
￿
￿
'
I
;
  . When
ˆ
￿
￿
￿ ,
no decrease is allowed from the originally planned sample size,
2 .
3.5 Properties of variance spending tests
By design, a variance spending test has Type I error probability
￿ . Further properties depend on how the
sample size inﬂation factor
X is chosen in the light of ﬁrst stage data. The fact that the ﬁnal test statistic
[
deﬁned by (4) is not a function of a sufﬁcient statistic for
& gives some cause for concern. Of course, the
unequal weighting of ﬁrst and second stage observations is necessary to ensure independence of
m
F and
m
  and, indeed, the argument of Section 3.2 shows the ﬁnal test must have this form if Type I error rate
￿ is to be maintained when unplanned design changes take place. Nevertheless, it is instructive to make
11Table 1: Inefﬁciency of a variance spending test with
I
w
￿
#
￿
¯
$ , as given by equation (13), and relative cost
of re-starting the trial afresh with increased power.
T 0.5 0.6 0.8 1 2 3 4 10
˘
Inefﬁciency of
[
2 1.44 1.06 1 1.25 1.44 1.56 1.81 2
Relative cost to re-start 3 2.39 1.78 1.50 1.12 1.06 1.03 1.01 1
comparisons with trial designs the experimenters could have chosen had they anticipated the possibility of a
smaller effect size before commencing the study.
An initial measure of possible inefﬁciency can be obtained from the derivation of the rule for choosing
X in Section 3.4. There, we noted that the sample size needed for a ﬁxed sample test designed to achieve
power
￿
￿
￿
￿
￿ at
&
?
￿
￿
￿
=
V
b
T is
T
 
2 per treatment arm, where
2 is given by (1). In contrast, a variance spending
test adapting an initial design with power
￿
￿
￿
˙
￿ at
&
o
￿
¨
￿ when an estimate
J
&
F
￿
¨
￿
=
V
b
T is observed at an
interim analysis requires
2
p
￿
￿
I
8
X
3
￿
S
￿
￿
I
;
￿
￿
2 observations per arm where
X
￿
￿
3
T
0
￿
￿
I
;
 
￿
V
3
￿
.
￿
￿
I
;
  . The
inefﬁciency of the variance spending test is thus
￿
I
8
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3
￿
W
￿
￿
I
;
￿
￿
2
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2
￿
¶
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I
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￿
/
I
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￿
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￿
￿
I
•
￿
T
 
￿ (13)
Table 1 shows numerical values of this measure of inefﬁciency for the case
I
￿
￿
#
￿
%
$ , i.e., when the trial is
re-designed after half the originally planned sample size. In the limit as
T
o
˚
˘ , the second stage term
m
  contributes essentially all the information about
& and this is diluted by adding
m
F which has the same
variance but, by comparison, negligible information about
& ; the situation is reversed as
T decreases to
I
0
￿
#
￿
%
$ where, in the limit, all the information about
& comes from
m
F .
Particularly when
T is much greater than
￿ , experimenters may be tempted to abandon the original
experiment, discard the observations, and start a new ﬁxed sample trial with power
￿
.
￿
/
￿ at
&
*
￿
￿
￿
=
V
b
T . This
new trial would require
T
 
2 observations per treatment arm in addition to the
I
2 in the abandoned study.
The “relative cost” in the bottom line of Table 1 is the ratio of the total sample size,
I
2
8
T
 
2 , involved in
this strategy to the sample size of
T
￿
 
2 needed by a ﬁxed sample test designed from the outset with power
￿
.
￿
￿
￿ at
&
￿
￿
¸
￿
=
V
b
T . When
3
T
S
￿
}
￿
;
 
'
,
«
￿
S
￿
n
I , i.e., when
T
-
,
«
￿
￿
￿
%
￿
￿
￿ for the case
I
w
￿
#
￿
¯
$ , starting a fresh trial
would be more efﬁcient than using the variance spending test. However, as mentionedpreviously, this is not
really a valid option since it inﬂates the overall Type I error rate.
The “inefﬁciencies” in Table 1 are suggestive of the cost of using a non-sufﬁcient statisticin the variance
spending method. They do not, however, take account of the variability in
J
&
F as an estimate of
& and the
12resulting random distribution of the factor
X . A proper assessment of the overall performance of a variance
spending test requires integration over the distribution of
J
&
F , which is normal with mean
& and variance
￿
=
V
3
I
2
;
.
If anything, the variation in second stage sample size could have a detrimental effect. Consider a study
with a random sample size of
‘
observations per treatment arm, where
‘
is not itself inﬂuenced by the
observations values. A hypothesis test of
(
) :
&
￿
￿
#
conducted with Type I error rate
￿ conditional on the
value of
‘
has power
˝
￿
C
3
\
‘
&
￿
￿
4
b
6
￿
;
￿
￿
Since
C
3
5
¤
Q
;
is an increasing,concave function of
¤
for
¤
,
#
and
\
‘
&
!
￿
4
b
6
is concave in
‘
, theconditional
power
C
3
\
‘
&
‡
￿
4
7
6
￿
;
is concave in
‘
when
\
‘
&
‡
￿
4
b
6
,
#
, i.e., for values of
‘
which give power at least
#
￿
%
$ . It follows by Jensen’s inequality that, when
‘
varies in this range, overall power is maximized if
‘
is
equal to its expectation with probability one, i.e., when sample size does not in fact vary. Under the initial
design, there is a good chance of distinguishing between the cases
&
H
￿
#
and
&
H
￿
@
￿ using a sample of
2
observations per treatment arm. At an intermediate stage with only a fraction of these observations,
J
&
F is
liable to vary over the range zero to
￿ , leading to considerable variation in the sample size implied by (11)
and (12). We should not, therefore, be surprised if a variance spending test has rather low power for its
expected sample size.
The power of the variance spending test can be calculated as
￿
￿
￿
￿
Reject
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)
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￿
￿
￿
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,
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￿
￿
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J
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￿
￿
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3
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l
￿
J
&
F
￿ (14)
It follows from the deﬁnition of
[
and the distribution of
m
  stated in (3) that
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The density of
J
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—
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￿
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￿
￿
￿
I
2
￿
3
J
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￿
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￿
and hence (14) can be evaluated numerically. The expected sample size per treatment arm or Average
Sample Number (ASN) is
ASN
￿
˝
3
2
p
;
￿
˜
I
2
8
1
3
￿
￿
￿
R
I
;
2
￿
X
3
J
&
F
;
_
￿
￿
3
J
&
F
;
l
￿
J
&
F
which, again, is readily evaluated by numerical integration.
13In the next section we shall apply the above formulae to evaluate the power function and ASN curve
of a representative example of a variance spending test. We then use these results to assess the price one
may have to pay for the ﬂexibility of the variance spending approach as compared to other less ﬂexible
procedures.
4 An example
4.1 Sampling and stopping rules
We shall use the following example to evaluate a typical variance spending test by the standard criteria of
power and expected sample size functions. The original plan is for a ﬁxed sample test and sample size
is modiﬁed at an intermediate analysis using the adaptation of Cui et al’s (1999) sampling rule described
in Section 3.4; early stopping introduced at the interim analysis allows
(
) to be accepted for sufﬁciently
poor responses. Although the results presented here are for this single example, we have found very similar
results in a variety of other examples using different values of
I ,
￿
and
ˆ , or calculating second stage
sample size by the conditional power formula (9) proposed by Fisher (1998).
As before, observations on treatments
￿ and
￿ are distributed as
￿
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￿
j
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￿
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;
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￿
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￿
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￿
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￿
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;
, interest is in the parameter
&
u
￿
"
￿
￿
￿
"
￿ , and the null hypothesis
(
*
) :
&
u
￿
#
is to be tested
againstthe one-sidedalternative
&
'
,
#
withTypeI errorrate
￿
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￿
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￿
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$ . In thenon-sequentialtestoriginally
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￿
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per treatment arm. Intermediate data are examined halfway through the trial, i.e.,
I
w
￿
#
￿
%
$ , and the second
stage sample size is inﬂated by the factor
X
3
J
&
F
;
deﬁned by (11) and (12) using
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￿
￿
e and
ˆ
￿
#
￿
¯
$ .
Speciﬁcally,
J
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￿
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second stage sample increases if
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￿
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As it stands, whenever
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¨
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￿
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¢
￿ this rule gives
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￿ , the value associated with a
test achieving power
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￿ . In order to save sample size when there is little prospect of a
positive outcome, we add a futility boundary at the ﬁrst stage which stipulates stopping to accept
(
*
) if the
conditional probabilityof rejecting
(
*
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&
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￿
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At the other extreme, substituting
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￿ . In practice one might prefer
to take a single observation on each treatment — but as
X will be small, the expectation of
X
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i
  will be
close to zero and the main role of this term is still to contribute the required amount to the variance of
[
.
4.2 Power and ASN functions
Figure 1 shows the power function of the variance spending test along with that of the original ﬁxed sample
size test. It is evident that the variance spending test has been successful in increasing power over the range
of
& values. After a sharp initial rise, its power function increases slowly as
& moves from around
#
￿
￿
c
￿
￿ to
￿
and the overall shape of the power curve is quite different from that of any ﬁxed sample test.
The argument of Section 3.1 that power is greater than
￿ for all positive
& does not readily extend to
prove that the power function increases monotonely with
& . Indeed, a general result is not possible since
examples exist where power is not monotone. The power function in Figure 2 is for a sampling rule similar
to our example but with
T replaced by the maximum of
T
￿
  and
#
￿
%
$ : after rising to
#
￿
￿
￿
￿
￿
b
e at
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￿
￿
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￿
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￿
￿
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￿
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&
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￿
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￿
￿ before starting to increase again.
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15Figure 1: Power of the variance spending (VS) test and the originally planned ﬁxed sample size test with
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) , while
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and a standard
4
-test calculated from all
2
p observations per treatment would not reject
(
*
) . Denne (2001)
notes an analogous problem in adaptive group sequential tests and we may choose to follow his suggestion
for such a situation, rejecting
(
) only if both conditions (15) and (16) are satisﬁed. Although this lowers
both Type I error rate and power, the effect is surprisingly small and the maximum reduction in the variance
spending test’s power at any point is less than
#
￿
#
￿ .
Figure 3 compares properties of the variance spending test with the ﬁxed sample test that has power
#
￿
￿
￿
at
&
o
￿
#
￿
￿
￿
￿
￿ . The left hand panel shows the difference in the shapes of the two power curves, the ﬁxed
sample test having the greater power for
&
'
,
#
￿
￿
￿
￿
￿ but the lower power, by some margin, at smaller
& values.
The ASN per treatment arm of the variance spending test is plotted in the right hand panel of Figure 3,
expressed in units of
2
￿
¸
￿
#
￿
%
$
￿
￿
=
V
￿
￿
  , the number of observations per arm originally planned. The steep rise
in ASNas
& decreasesfrom
￿ towards zero is in keeping withthe goalof a samplesize inverselyproportional
16Figure 2: Non-monotone power function of an adaptively deﬁned test.
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
q/d
P
o
w
e
r
to
&
  for
& between
#
￿
%
￿
￿
$
¢
￿ and
￿
¢
￿ that motivated this sampling rule. The variation in ASN is substantial
with values around
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2 for
& near zero compared to
c
2 or less for
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w
,
1
￿ . In contrast, the ﬁxed sample test
has constant sample size of
2
V
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2 . If it had been realized at the outset that greater power was
desirable, this ﬁxed sample test would have been an attractive candidate, offering broadly similar gains in
power to the variance spending test for a generally lower sample size.
4.3 Lack of efﬁciency of the variance spending test
In Section 3.5 we presented a measure of possible inefﬁciency in the variance spending test due to its use
of a non-sufﬁcient statistic for
& . The high ASN seen in Figure 3 relative to that of a ﬁxed sample test
with broadly similar power curve is further evidence of such inefﬁciency. Figure 4 compares the variance
spending test’s ASN function with the ﬁxed sample size needed to obtain the same power at each individual
value of
& . Since this ﬁxed sample size varies with
& , the values plotted on the line labeled FSS do not
represent the ASN curve of any particular test, but this is still a reasonable point of comparison: many
sequential and group sequential tests would have a lower ASN at each value of
& in such a comparison.
17Figure 3: Power and ASN of the variance spending (VS) test and a ﬁxed sample size test with power
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￿ equally weighted observations per treatment arm. We therefore deﬁne the effective
sample size in the variance spending test as
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A little algebra shows that
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ı . The average effective sample size for our example test (with
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￿
ß
ª
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￿
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￿ ),
labeled ESS in Figure 4, lies below the ASN but, for the most part, above the equivalent ﬁxed sample size,
FSS. Thus, at most
￿ values, power is still less than one might expect given the average effective sample
size.
The remaining lack of power can be attributed to the variability in
ø
eff, along the lines of the discussion
of variable sample size in Section 3.5. As an example, consider the case
￿
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￿
1
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Ł . The density of
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￿ when
18Figure 4: ASN and average effective sample size (ESS) of the variance spending test compared to the ﬁxed
sample size (FSS) needed to obtain the same power at each individual value of
& .
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&
￿
￿
#
￿
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￿ is shown in the left hand panel of Figure 5 and the resulting distribution of
‘
eff in the right hand
panel. This distribution comprises a density plus two point probability masses arising from
T
￿
￿
#
￿
¯
$ and
e ,
for which
X
o
￿
#
and
e
￿
￿ and
‘
eff
￿
2
V
=
e and
￿
b
￿
2 respectively. The average effective sample size,
￿
k
￿
￿
￿
=
￿
2 ,
is noticeably less than the ASN of
￿
k
￿
#
￿
#
2 . A size
￿
–
￿
#
￿
#
￿
￿
$ ﬁxed sample test with
￿
k
￿
￿
￿
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￿
2 observations per
treatment arm has power
#
￿
￿
￿
￿
￿
￿
￿ at
&
-
￿
#
￿
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￿ . If, however, a test is carried out with a random sample size
taken from the distribution of
‘
eff using a conditional signiﬁcance level
￿ given the observed sample size,
its overall power is only
#
￿
¯
￿
#
c . The variance spending test’s power of
#
￿
￿
￿
￿
e
￿
￿ lies between these two values,
indicating that it suffers from the effects of the variable sample size but these are partly ameliorated by the
way in which
X depends on
i
F : low values of
X are chosen when
i
F is high and good conditional power can
be achieved with a small number of additional observations, while high values of
X occur when
i
F is low
and a higher stage two sample size provides a substantial rise in conditional power. We note, however, that
this beneﬁcial effect is of limited value since, as the line FSS in Figure 4 shows, a ﬁxed sample size of just
19Figure 5: Density of
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￿ (left panel) and consequent distribution of
‘
eff (right panel).
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c
k
￿
￿
e
#
2 per arm is all that is needed to achieve the variance spending test’s power of
#
￿
￿
￿
￿
e
￿
￿ in a simple, ﬁxed
sample test.
One can ask whether better results might have been obtained if the ﬁrst and second stage data had been
combined through some other test statistic. As explained in Section 3.2, use of such a test is only allowable
if designated in the initial protocol, thus, this is not a legitimate option in the scenario of an unplanned
interim analysis in what was intended to be a simple ﬁxed sample size trial. Bauer & Köhne (1994) use
R.A. Fisher’s method for combining
￿
-values for a one-sided test of
(
) :
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#
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#
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￿ distribution. For
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˙
￿
#
￿
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￿
￿
$ , the critical value for
G
F
G
  is
#
￿
#
￿
#
c
￿
￿ . Combining this rule with the sampling rule of our example, produces a fairly similar power curve
to that of the variance spending test: the curves cross twice between
&
w
￿
#
and
&
w
￿
￿
￿ and are within
#
￿
#
c
20of each other everywhere. However, the power of Fisher’s combination test does approach one more rapidly
and the difference between, for example, power
#
￿
￿
￿
￿
￿
￿
￿ for Fisher’s test and
#
￿
￿
￿
￿
￿
￿
￿ for the variance spending
test at
&
w
￿
D
￿ may be regarded as signiﬁcant. More might have been expected of Fisher’s combination test
in view of the very good power properties of this test in a simpler application reported by Bauer & Köhne
(1994, Table3); however, it shouldbe notedthatthe designinour example,in particulartherule forstopping
for futility at the ﬁrst analysis, is not tailored to Fisher’s test.
4.4 Competing group sequential tests
In Section 4.2 we compared the variance spending test with a ﬁxed sample test achieving similar overall
power. This ﬁxed sample design could have been chosen if the experimenters had anticipated the need for
greater power. In this case, there are other options too: group sequential tests can satisfy error probability
requirements with lower average sample size than ﬁxed sample tests. Error spending group sequential tests
are a currently popular choice and have the ability to deal with variation in observed group sizes about their
intended values. We shall present results for one-sided error spending tests in the “
￿ -family” described by
Jennison & Turnbull (2000, Section 7.3); for simplicity, we present results when group sizes are actually
equal to their planned values. The tests described below are chosen to dominate the variance spending test
in terms of both power and ASN for
& values in the region of primary interest between zero and
￿ .
The two-stage, one-sided group sequential test shown in Figure 6 has Type I error rate
#
￿
#
￿
￿
$ and power
#
￿
￿
￿ at
&
w
￿
#
￿
￿
c
￿
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￿
￿ . The form of stopping boundary is quite standard, namely a
￿ -family error spending test
with
￿
w
￿
￿
￿ . An unusual feature of the design is the timing of the ﬁrst analysis after just
￿
￿
￿
%
$
2 observations
per treatment, one fourth of the maximum sample size: this allows sufﬁciently early stopping to make good
reductions in ASN at parameter values near
&
￿
￿
¸
￿ , where power is very close to one. Setting power
#
￿
￿
￿ at
&
u
￿
#
￿
￿
c
￿
c
￿
￿ ensures that the group sequential test’s power curve lies completely above that of the variance
spending test. The left hand panel of Figure 7 shows that, in addition, the group sequential test provides
much greater power for values of
& around
#
￿
￿
c
￿
￿ and above. At the same time, the ASN curves in the right
hand panel demonstrate that this is achieved with considerably lower average sample size. Furthermore, the
group sequential test’s maximum sample size of
￿
#
￿
#
2 per treatment arm is far below that of
￿
￿
$
2 for the
variance spending test.
A two-stage group sequential test is comparable with the variance spending test in that both have a total
of two analyses. However, the variance spending test has the freedom to vary the second stage group size
in the light of ﬁrst stage data while that of the group sequential test is pre-determined. Careful timing of a
21Figure 6: A two-stage, one-sided group sequential test of
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group sequential test’s early analyses helps attain low average sample sizes at the higher values of
& , where
power is close to one. This is evident in the above two group design where the ﬁrst analysis is set at one
quarter of the total sample size. The ﬁve and ten-stage, one-sided group sequential boundaries shown in
Figures 8 and 9 are also for
￿ -family error spending tests with
￿
￿
￿
￿
￿ . Both tests have Type I error rate
#
￿
#
￿
￿
$
and power
#
￿
￿
￿ at
&
￿
￿
#
￿
￿
c
￿
c
￿
￿ and their power curves are indistinguishable from that of the two-stage test
in Figure 6. The ﬁve-stage test has its ﬁrst analysis at one tenth of the total sample size, with equal group
sizes thereafter, while the ten-stage test has ten equally sized groups. The ASN curves in Figure 10 show
the usual improvements in ASN arising from more frequent analyses and particular improvement at higher
values of
& , helped by the additional, well placed, early analyses. Again, the maximum sample sizes per
treatment arm of
￿
￿
￿
￿
￿
￿
e
2 for the ﬁve group test and
￿
￿
￿
￿
￿
￿
￿
2 for the ten group test are well below the variance
spending test’s
￿
￿
$
2 .
These comparisonswithstandardgroupsequential designs illustratethe cost of ﬂexibility inthe variance
spending approach. The increased power and reduced sample size of the group sequential tests argue
eloquently for more careful consideration of the appropriate power requirement well before a trial gets
22Figure 7: Power and ASN curves of the variance spending (VS) test and two-stage group sequential test.
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under way.
5 Discussion
There is no dispute that a variance spending test can rescue a trial from a poor initial design. The ﬂexibility
of these tests can also be used to adapt a trial to a change in treatment deﬁnition (such as a new dosage
or selection of one dose from the range of doses used initially), or to the substitution of an alternate
endpoint; see, for example, Bauer & Köhne (1994), Bauer & Röhmel (1995), Fisher (1998) and Lehmacher
& Wassmer (1999). In another form of adaptation, Wang, et al (2001) use Cui et al’s (1999) method to
create a group sequential test which can switch adaptively between hypothesis tests of superiority and non-
inferiority.
It may not be so obvious that this ﬂexibility can come at a substantial price. Our evaluations have been
in the context of changing a trial’s sample size in mid-course in order to attain power at a smaller effect
size than originally anticipated. The message here is clear: a variance spending test can require many more
observations than a group sequential test with superior power. Thus, consideration should be given at the
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planningstagetowhat is desirableforthe full rangeof possibleeffect sizes, includingthose deemedunlikely
at that point.
The example of a variance spending test studied in Section 4 has a single re-design point and limited
opportunity for early stopping at this time. Fisher (1998) and Shen & Fisher (1999) also propose designs
with more frequent re-assessment of the target sample size. Cui et al (1999) follow a different approach,
incorporating sample size changes within an initial group sequential test which can terminate with rejection
or acceptanceof
(
) atany stage. We areinvestigatingthese methodstoo andshallreportonthem elsewhere.
As long as the experimenters’objectives can be properlyestablished atthe outset, there are good reasons
to expect standard group sequential designs to dominate variance spending tests. Knowing the correct goal
helpsdesignthetrialefﬁciently, useofasufﬁcientstatisticisinkeepingwithfundamentalprinciples,andone
can choose from tests optimized to a selection of criteria (see Barber & Jennison, 2001). Variance spending
tests have the special feature that future group sizes can be adapted to previously observed responses. The
extension of group sequential tests to “sequentially planned” designs proposed by Schmitz (1993) provides
this property, which may be of value when only a small number of groups are permitted. However, we
24Figure 9: A ten-stage, one-sided group sequential test of
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should not let consideration of these more complex designs obscure the excellent performance, seen in our
example, of standard group sequential tests with pre-speciﬁed group sizes.
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